Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity

Completed · Phase 2

Conditions studied: Other (or Unknown) Substance Use Disorders

In brief

The aim of the current study is to develop and pilot test an anxiety sensitivity-based intervention for co-occurring substance use disorders (SUDs) and anxiety. Research questions include determining whether a broadly-applicable AS-based intervention can significantly decrease both substance misuse and anxiety. Secondary aims include examining the impact of this intervention on general functioning and depressive/anxious symptoms. In phase I, an initial pilot was conducted to examine the feasibility, safety, and patient satisfaction with the protocol, and to estimate potential efficacy of the protocol. In phase II, participants will be randomized to the intervention or a control condition.

Key facts

Study ID

NCT02667015

Run by

Hartford Hospital

People needed

41

Starts

2012-05-01

Expected to finish

2015-05-01

Last updated by the study team

2016-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• score higher than 25 (established clinical cutoff) on the Anxiety Sensitivity Index (ASI; Peterson \& Plehn, 1999)
• meet the DSM diagnostic criteria for current substance abuse or psychological dependence

You may not qualify if…

• active psychosis, suicidality, mania, or current physiological withdrawal symptoms that necessitate medical detoxification; no substance use in the past 3 months

Where it is running

• Institute of Living/Hartford Hospital — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.